Majority stake drives growth in the Peruvian market
Holcim has announced the acquisition of a majority stake in the Peruvian construction company Cementos Pacasmayo. The transaction, with a volume of USD 1.5 billion, is intended to strengthen Holcim's presence in Latin America and is a central component of the NextGen Growth 2030 Strategy.
The Zug-based building materials company Holcim has announced the acquisition of a majority stake in the Peruvian building materials company CementosPacasmayo. With this transaction, Holcim is strengthening its presence in the growth market of Latin America and pursuing its NextGen Growth Strategy 2030, according to the press release.
Cementos Pacasmayo is forecasting net sales of USD 630 million and an EBITDA margin of 28 per cent in 2025. The transaction volume of USD 1.5 billion thus corresponds to 8.8 times the EBITDA forecast for 2025. The acquisition is expected to have a positive impact on earnings per share (EPS) and free cash flow in the first year and on return on investment (ROIC) in the third year.
“The synergetic acquisition of Cementos Pacasmayo is in line with our ‘NextGen Growth 2030’ strategy to accelerate growth in the attractive Latin America region,” Holcim CEO Miljan Gutovic is quoted as saying. “This is an opportunity to continue the exceptional legacy of Cementos Pacasmayo, based on a strong performance culture, a deep commitment to its employees and a highly recognised brand in Peru. The company is highly cash-generative and has a complementary portfolio of building materials and construction solutions. I look forward to welcoming Pacasmayo’s 2,000 employees to Holcim and continuing to grow together.”
The approximately 300 points of sale of Cementos Pacasmayo will complement Holcim’s presence in Latin America. Holcim had already entered the Peruvian building materials market last year with the acquisitions of Comacsa, Mixercon and Compañía Minera Luren.
The transaction, which is expected to close in the first half of 2026, is in line with Holcim’s growth-oriented capital allocation and is subject to customary regulatory approvals.